Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
Frontier Capital Management Co. LLC Increases Position in bluebird bio Inc (NASDAQ:BLUE)
09:06am, Sunday, 19'th Apr 2020
Frontier Capital Management Co. LLC raised its position in bluebird bio Inc (NASDAQ:BLUE) by 24.7% during the first quarter, according to the company in its most recent disclosure with the Securities
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period
09:00am, Friday, 17'th Apr 2020
The gene therapy market is projected to grow at a CAGR of 32% in the first half of the forecast period. In 2019, the cancer treatment submarket accounted for 55.8% of the gene therapy drug market. Vis
bluebird bio: Several Delays Hit By COVID-19
08:02pm, Wednesday, 15'th Apr 2020
In my last article, I discussed how bluebird was transitioning into a commercial company with its progress in its clinical programs. Since then, due to the COVI
Morgan Stanley Maintains Equal-Weight on bluebird bio, Lowers Price Target to $69
12:00am, Wednesday, 15'th Apr 2020Norges Bank Buys Shares of 474,488 bluebird bio Inc (NASDAQ:BLUE)
10:48am, Sunday, 12'th Apr 2020
Norges Bank bought a new stake in shares of bluebird bio Inc (NASDAQ:BLUE) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 474,488 shares of the biote
bluebird bio Inc (NASDAQ:BLUE) Shares Sold by Ladenburg Thalmann Financial Services Inc.
09:08am, Sunday, 12'th Apr 2020
Ladenburg Thalmann Financial Services Inc. decreased its stake in shares of bluebird bio Inc (NASDAQ:BLUE) by 7.5% during the fourth quarter, according to its most recent 13F filing with the Securitie
bluebird bio (NASDAQ:BLUE) Trading Up 8%
10:44am, Saturday, 11'th Apr 2020
bluebird bio Inc (NASDAQ:BLUE)’s share price was up 8% during trading on Thursday . The stock traded as high as $47.53 and last traded at $46.50, approximately 1,842,149 shares changed hands during
bluebird bio Inc (NASDAQ:BLUE) Insider Sells $25,494.59 in Stock
09:44am, Saturday, 11'th Apr 2020
bluebird bio Inc (NASDAQ:BLUE) insider Joanne Smith-Farrell sold 583 shares of the business’s stock in a transaction dated Monday, April 6th. The stock was sold at an average price of $43.73, for a
Alliancebernstein L.P. Purchases 28,000 Shares of bluebird bio Inc (NASDAQ:BLUE)
08:22am, Saturday, 11'th Apr 2020
Alliancebernstein L.P. lifted its position in bluebird bio Inc (NASDAQ:BLUE) by 107.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institution
Recent Investment Analysts' Ratings Updates for bluebird bio (BLUE)
09:04am, Friday, 10'th Apr 2020
A number of firms have modified their ratings and price targets on shares of bluebird bio (NASDAQ: BLUE) recently: 4/4/2020 – bluebird bio was downgraded by analysts at BidaskClub from a “sell”
Why bluebird bio Stock Soared Today
07:36pm, Thursday, 09'th Apr 2020
A major move by the Fed lifted the entire stock market, including this biotech stock.
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 3,725 bluebird bio Inc (NASDAQ:BLUE)
09:30am, Wednesday, 08'th Apr 2020
Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of bluebird bio Inc (NASDAQ:BLUE) in the fourth quarter, according to the company in its most recent disclosure with t
Nuveen Asset Management LLC Increases Holdings in bluebird bio Inc (NASDAQ:BLUE)
11:50am, Tuesday, 07'th Apr 2020
Nuveen Asset Management LLC grew its holdings in shares of bluebird bio Inc (NASDAQ:BLUE) by 21.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commissio
29,205 Shares in bluebird bio Inc (NASDAQ:BLUE) Acquired by Janus Henderson Group PLC
10:58am, Tuesday, 07'th Apr 2020
Janus Henderson Group PLC bought a new position in shares of bluebird bio Inc (NASDAQ:BLUE) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 29,
